UNSPSC 51143708: Dextromethorphan/quinidine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN900. This VA Drug Class (CN900) classifies this compound as belonging to the group CNS MEDICATIONS, OTHER.

UNSPSC 51143708 Dextromethorphan/quinidine is a Commodity code nominally covering branded pharmaceutical combinations, but recent state and local procurement activity shows a substantial mismatch with the code's scope. Seminole County, Florida tagged a competitive bid (IFB 60459723LAS, posted June 30, 2026, due July 26, 2026) for naloxone and drug deactivation systems under this code, though neither product aligns with the pharmaceutical combination the code describes. The county is seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, delivered quarterly to the Seminole County Community Health Building in Sanford, Florida. Vendors must submit bids electronically, include all shipping and delivery costs in proposals, hold workers' compensation and general liability insurance, comply with drug-free workplace and E-Verify requirements, and accept a three-month probationary termination clause. The initial contract term is two years with a one-year renewal option. The procurement may be funded through FEMA and carries federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act.

The single identified opportunity suggests limited recent activity under this code in the state and local space. Seminole County's naloxone and deactivation-system procurement appears to be the primary visible use of UNSPSC 51143708 in state and local government buying, though the tagging appears inconsistent with the code's pharmaceutical classification. No geographic spread across multiple jurisdictions or states is evident from the available record, and no repeat issuing bodies have solicited under this code. This code shows little relevant recent activity for business development purposes when evaluated against its nominal scope.